Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis
- 1 March 2015
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 36 (3) , 1603.e11-1603.e14
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81125009)
This publication has 35 references indexed in Scilit:
- ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosisNeurobiology of Aging, 2013
- Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosisNature, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- Ataxin-2 repeat-length variation and neurodegenerationHuman Molecular Genetics, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Ataxin-2 intermediate-length polyglutamine expansions in European ALS patientsHuman Molecular Genetics, 2011
- Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALSNeuron, 2010
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993